XML 19 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED COMPENSATION
9 Months Ended
Sep. 30, 2013
STOCK-BASED COMPENSATION [Text Block]

11.      STOCK-BASED COMPENSATION

Stock Options

The Company has granted incentive and non-qualified stock options to its employees and directors under its 2006 Stock Incentive Plan. The Company has also granted non-qualified, non-plan stock options, which have been authorized by the Company’s board of directors. Stock options are generally granted at an exercise price equal to or greater than the quoted market price on the date of grant.

There are 4,431,744 stock options outstanding at September 30, 2013 issued pursuant to the Company’s 2006 Stock Incentive Plan. The outstanding options expire at various dates from 2013 to 2017. The Company did not grant any stock options during the three and nine month periods ended September 30, 2013. During the three and nine month periods ended September 30, 2013, the Company recognized $3,842 and $23,209, respectively, in compensation expense related to employee stock options that vest over time. The Company did not grant any stock options during the three and nine month periods ended September 30, 2012. During the three and nine month periods ended September 30, 2012, the Company recognized $13,075 and $62,597, respectively, in compensation expense related to employee stock options that vest over time.

As summarized in the following tables, during the three and nine month periods ended September 30, 2013, there were no stock options granted nor exercised, and 0 and 6,750 were cancelled or forfeited, respectively.

            Weighted  
      Number of     Average  
      Shares     Exercise Price  
  Three months ended September 30, 2013            
  Options outstanding at June 30, 2013   4,431,744   $ . 18  
   Granted   -     -  
   Exercised   -     -  
   Cancelled/Forfeited   -     -  
               
  Options outstanding at September 30, 2013   4,431,744   $ . 18  

            Weighted  
      Number of     Average  
      Shares     Exercise Price  
  Nine months ended September 30, 2013            
  Options outstanding at December 31, 2012   4,438,494   $ . 18  
   Granted   -     -  
   Exercised   -     -  
   Cancelled/Forfeited   (6,750 )   .16  
               
  Options outstanding at September 30, 2013   4,431,744   $ . 18  

The following table summarizes certain additional information about the Company’s total and exercisable stock options outstanding as of September 30, 2013:

            Weighted              
            Average     Weighted        
            Remaining     Average        
      Number     Contractual     Exercise     Intrinsic  
      Outstanding     Life in Years     Price     Value  
                           
  Total stock options   4,431,744     1.9   $ . 18   $   -  
  Exercisable stock options   4,224,994     2.0   $ . 18   $   -  

The closing price of the Company’s common stock on the OTCQB Market on September 30, 2013 was $0.03 per share. Accordingly, the intrinsic values of total stock options and exercisable stock options as of September 30, 2013 was $0.

The following table summarizes the unvested stock options outstanding as of September 30, 2013:

            Weighted Average  
            Grant Date  
      Number of Shares     Fair Value  
  Three months ended September 30, 2013            
  Unvested options outstanding at June 30, 2013   604,997   $ . 10  
   Granted   -     -  
   Vested   (398,247 )   .08  
   Cancelled/Forfeited   -     -  
               
  Unvested Options outstanding at September 30, 2013   206,750   $ . 11  
            Weighted Average  
            Grant Date  
      Number of Shares     Fair Value  
  Nine months ended September 30, 2013            
  Unvested options outstanding at December 31, 2012   811,747   $ . 11  
   Granted   -     -  
   Vested   (604,997 )   .09  
   Cancelled/Forfeited   -     -  
               
  Unvested Options outstanding at September 30, 2013   206,750   $ . 11  

The total grant date fair value of options vested during the three and nine month periods ended September 30, 2013 was $33,333 and $56,634, respectively. The Company recognizes stock option compensation expense on stock options with a graded vesting schedule on a straight line basis over the requisite service period for each separately vesting portion of the award as if the award was, in substance, multiple awards. As of September 30, 2013, 206,750 stock options remain unvested, which will result in $6,539 in compensation expense to be recognized during the next nine months.

Deferred Stock Units

During the three and nine months ended September 30, 2012, certain equity-based fees have been paid to the Company’s non-executive directors in the form of awards issued pursuant to the Company’s 2006 Stock Incentive Plan. The non-executive directors have limited rights, exercisable within applicable time limits, to elect to have any percentage of such awards, and any percentage of cash fees, payable in deferred stock units. Each of the Company’s non-executive directors exercised such rights in respect of the equity-based fees payable to him for the three and nine months ended September 30, 2012.

During the three and nine months ended September 30, 2012, Douglas Hamilton, the Chairman of the Company’s Audit Committee, received 210,525 and 518,650 deferred stock units, respectively; John Cook, the Chairman of the Company’s Compensation Committee, received 171,053 and 421,403 deferred stock units, respectively; Stephen Seymour, the Chairman of the Company’s Corporate Governance and Nominating Committee, received 171,053 and 421,403 deferred stock units, respectively. During the three and nine months ended September 30, 2012, the Company recognized expense of $26,250 and $78,750, respectively, related to the issuance of deferred stock units to its independent directors. The deferred stock units were granted under the 2006 Deferred Stock Unit Plan, which forms part of the Company’s 2006 Stock Incentive Plan.

During the three and nine months ended September 30, 2013, 0 and 790,721 deferred stock units were converted into shares of the Company’s common stock, respectively. As of September 30, 2013, there were 3,592,179 deferred stock units outstanding.